Comparison of ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 55-60

  Rottinghaus, Erin ^a   Bile, Ebi ^b   Modukanele, Mosetsanagape ^b   Maruping, Maruping ^b   Mine, Madisa ^c   Nkengasong, John ^a   Yang, Chunfu ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Department of HIV AIDS Prevention and Care   (Botswana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; DRIED BLOOD SPOT TESTING; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; VIROLOGY; VIRUS DETECTION; VIRUS LOAD;

ADULT; BOTSWANA; DESICCATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871673404     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02002-12     Document Type: Article

References (26)

1. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. 2008. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir. Ther. 13(Suppl 2):1-13. (Pubitemid 352019085)
2. Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D. 2008. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antivir. Ther. 13(Suppl 2):15-23. (Pubitemid 352019086)
3. WHO. 2010. WHO manual for HIV drug resistance testing using dried blood spot specimens. WHO, Geneva, Switzerland.
4. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF. 2009. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir. Ther. 14:619-629.
5. Bertagnolio S, Soto-Ramirez L, Pilon R, Rodriguez R, Viveros M, Fuentes L, Harrigan PR, Mo T, Sutherland D, Sandstrom P. 2007. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 12:107-113. (Pubitemid 46340432)
6. Buckton AJ, Bissett SL, Myers RE, Beddows S, Edwards S, Cane PA, Pillay D. 2008. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J. Antimicrob. Chemother. 62:1191-1198.
7. Garrido C, Zahonero N, Fernandes D, Serrano D, Silva AR, Ferraria N, Antunes F, Gonzalez-Lahoz J, Soriano V, de Mendoza C. 2008. Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J. Antimicrob. Chemother. 61:694-698. (Pubitemid 351321149)
8. Hallack R, Doherty LE, Wethers JA, Parker MM. 2008. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay. J. Clin. Virol. 41:283-287.
9. Lira R, Valdez-Salazar H, Vazquez-Rosales G, Rojas-Montes O, Ruiz-Tachiquin M, Torres-Ibarra R, Cano-Dominguez C, Maldonado- Rodriguez A, Gomez A, Munoz O, Alvarez-Munoz MT. 2010. Genotypic testing for HIV-1 drug resistance using dried blood samples. Arch. Virol. 155:1117-1125.
10. Masciotra S, Garrido C, Youngpairoj AS, McNulty A, Zahonero N, Corral A, Heneine W, de Mendoza C, Garcia-Lerma JG. 2007. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 21:2503-2511. (Pubitemid 350145182)
11. McNulty A, Jennings C, Bennett D, Fitzgibbon J, Bremer JW, Ussery M, Kalish ML, Heneine W, Garcia-Lerma JG. 2007. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J. Clin. Microbiol. 45:517-521.
12. Steegen K, Luchters S, Demecheleer E, Dauwe K, Mandaliya K, Jaoko W, Plum J, Temmerman M, Verhofstede C. 2007. Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots. J. Clin. Microbiol. 45:3342-3351. (Pubitemid 47585660)
13. Yang C, McNulty A, Diallo K, Zhang J, Titanji B, Kassim S, Wadonda-Kabondo N, Aberle-Grasse J, Kibuka T, Ndumbe PM, Vedapuri S, Zhou Z, Chilima B, Nkengasong JN. 2010. Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance. J. Clin. Microbiol. 48:3158-3164.
14. Youngpairoj AS, Masciotra S, Garrido C, Zahonero N, de Mendoza C, Garcia-Lerma JG. 2008. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C. J. Antimicrob. Chemother. 61:1217-1220. (Pubitemid 351753584)
15. Ziemniak C, George-Agwu A, Moss WJ, Ray SC, Persaud D. 2006. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J. Virol. Methods 136:238-247. (Pubitemid 44051599)
16. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin. Infect. Dis. 49:976-981.
17. Monleau M, Butel C, Delaporte E, Boillot F, Peeters M. 2010. Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping. J. Antimicrob. Chemother. 65:1562-1566.
18. van Deursen P, Oosterlaken T, Andre P, Verhoeven A, Bertens L, Trabaud MA, Ligeon V, de Jong J. 2010. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0. J. Clin. Virol. 47:120-125.
19. Rottinghaus EK, Ugbena R, Diallo K, Bassey O, Azeez A, Devos J, Zhang G, Aberle-Grasse J, Nkengasong J, Yang C. 2012. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving firstline antiretroviral therapy. Clin. Infect. Dis. 54:1187-1195.
20. Zhou Z, Wagar N, DeVos JR, Rottinghaus E, Diallo K, Nguyen DB, Bassey O, Ugbena R, Wadonda-Kabondo N, McConnell MS, Zulu I, Chilima B, Nkengasong J, Yang C. 2011. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings. PLoS One 6:e28184. doi:10.1371/journal.pone.0028184.
21. Charpentier C, Gody JC, Tisserand P, Matta M, Fournier J, Mbitikon O, Belec L. 2011. Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria. Arch. Virol. 156:1603-1606.
22. CLSI. 2007. Approval standard. CLSI publication number LA4-A5. CLSI, Wayne, PA.
23. van Deursen P, Oosterlaken T, Andre P, Verhoeven A, Bertens L, Trabaud MA, Ligeon V, de Jong J. 2009. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0. J. Clin. Virol. 47:120-125.
24. Woods CK, Brumme CJ, Liu TF, Chui CK, Chu AL, Wynhoven B, Hall TA, Trevino C, Shafer RW, Harrigan PR. 2012. Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. J. Clin. Microbiol. 50:1936-1942.
25. Fleiss JL (ed). 1981. Statistical methods for rates and proportions, 2nd ed. John Wiley, New York, NY.
26. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310. (Pubitemid 16134762)